Acceptance rate 46%
Time to first decision 20 days*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2003 , Vol 45 , Num 2
Triplicate Design Bioequivalence Studies
Nasir M. Idkaidek

Istanbul Medipol University